- HHS agency launches $139.4M behavioral health research initiative
- Dell gifts push UT Austin support past $1B, fund new medical campus
- Hospital telehealth adoption by state
- CMS pauses weight-loss BALANCE model for Medicare
- Mayo Clinic backs virtual biomarker startup in $4.9M investment
- CMS to require state audits of all providers accepting Medicaid
- Texas ASC completes 1st artery embolizations with Regent Surgical platform
- Why independent dentistry is ready for a comeback
- UnitedHealthcare’s ‘deliberate trade-off’ for margin recovery
- Surgeons’ sex ruled out as driver of disparities in cardiac surgery: Study
- VCU Health creates new marketing leadership role
- Optum revenue hits $63.7B in Q1
- Wellstar CEO: Keeping care local while building across the Southeast
- What is ibogaine? 4 things to know
- Lexington Health names new CIO
- How Tenet turned a hospital company into the country’s largest ASC operator: 7 things to know
- What dentists need to know about the growing use of AI in healthcare
- 3 GI leaders keeping their practices independent in 2026
- 69% of DSOs plan to boost acquisitions in 2026: Report
- Minnesota ASC sees 1st Vanquish procedure in Midwest
- NADP appoints 1st dentist to permanent position
- Texas behavioral health provider reports breach affecting 285,000
- 5 new workforce statistics for dentists to know
- Heartland Dental to open $660K Florida office
- Heartland Dental adds RCM solutions to network
- Physician Partners of America adds another anesthesiologist
- Nonprofits to merge into national suicide prevention organization
- Community Health Systems reports low volumes, earnings dip for Q1 2026
- Prenatal medications linked to increased autism risk: 4 study notes
- What’s new with Ascension?
- Psych hospital’s security change draws scrutiny amid patient assaults
- 5 orthopedic leaders shaping ASC growth
- What 3 recent CON debates mean for the ASC industry
- The DSO de novo boom
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- What is ibogaine? 4 things to know
- Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
- Rush to open 60,000-square-foot Chicago wellness center
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- VideaHealth undergoes rebrand, extends to private practices
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Listen to the Latest ‘KFF Health News Minute’
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- Merger to create nation's largest suicide prevention nonprofit
- Oz previews new plan to push states toward revalidating Medicaid providers
- Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
- Covera Health, Medmo combine to create end-to-end diagnostic imaging platform
- The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions
- AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win
- In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
- Listen: Cheap Health Insurance Isn’t Always Cheap
- Real Estate Investors Profit From Long-Term Care While Residents Languish
- Democrats Demand Trump Administration Halt Plan To Collect Federal Workers’ Health Data
- UnitedHealth Group spotlights AI investments as part of operational turnaround
- ECRI spins out healthcare supply chain division into Staritas, backed by PE firm Accel-KKR
- UCB partners with Myasthenia Gravis Foundation of America on meal program targeting nutrition deserts
- Indiana University Southeast earns counseling accreditation
- Ohio safety-net provider to acquire behavioral health organization
- Replimune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
- Connecticut dentists among growing number of non-hospital clinicians suing patients over medical debt: Report
- 3 in 10 adults turn to digital tools for mental health: 4 study notes
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- 'Hospitals adverse to transparency'—clashing industry groups spar on mulligan 340B rebate pilot
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- A look inside Highmark and Spring Health's mental well-being partnership
- CVS, Mass General Brigham primary care deal would increase annual care spending by $40M, report predicts
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions
- Baby Food Recalled After Rat Poison Discovered in Jar
- Report Finds Drug Prices Rising Despite Trump Pricing Deals
- Trump Backs Psychedelic Research
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Hippocratic AI rolls out 2 new tools aimed at expanding clinical access, improving nurse workflow
- In Connecticut, doctors now sue patients most over medical bills, surpassing hospitals
- Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
- Physician burnout falls for third year in 2025 to 42%, AMA data shows
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Extra Antibiotic Doesn't Reduce Infection Risk During Surgery To Fix Complex Fractures, Trial Finds
- Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog
- E-Cigarette Taxes Won't Necessarily Cause An Increase In Smoking, Study Says
- Dreams Affect Your Morning Mood In Surprising Ways, Study Finds
- Weed Blunts Brain Development In Teens
- Genentech shifts Hemlibra marketing focus to patient stories as competition approaches
- An Arm and a Leg: The Accidental Architect of America’s Drug Patent Problem
- In Connecticut, Doctors Now Sue Patients Most Over Medical Bills, Surpassing Hospitals
- Neurogene hires new CCO as it eyes commercial future for its Rett gene therapy
- Biovac nets $108M finance package to build Africa’s first fully integrated vaccine plant
- Theramex exits self-regulatory body after ‘systemic’ compliance failures
- Trump orders FDA to fast-track reviews of psychedelic drugs after lobbying by podcaster
- Bayer falls short in bid to block J&J’s survival claims in prostate cancer clash
- Biogen bullish on America with Durham Bulls team up
- AbbVie launches ‘PSO Done’ psoriasis campaign with cross-agency effort
- DOJ seeks immediate asset freeze, receivership against telehealth company Zealthy
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
- Tu nuevo terapeuta: conversador, indiscreto… y difícilmente humano
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Oscar unveils Lucie, its one-stop shop for individual market plans, supplemental benefits
- Affordability, transparency: A look at large employers' top healthcare concerns
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- Remarks at the Options Market Structure Roundtable
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Beyond the Visit: How AI Companion Technology Is Reshaping Outcomes for Aging Populations
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors
- AI simulates real-world HCP feedback on pharma content
Answers in Genesis offers biblical perspective on current events, including healthcare news. It also discussed this topic in a news segment. Video at the link. (Clipped here for length.)
https://answersingenesis.org/sanctity-of-life/abortion/inventor-abortion-pill-dies-age-98/
A Deadly Legacy: Inventor of the Abortion Pill Dies at Age 98
June 12, 2025The Lord hates . . . hands that shed innocent blood. (Proverbs 6:16–17)
A French scientist, Étienne-Émile Baulieu, who recently died at the age of 98, is being hailed in headlines around the world as “a beacon of courage” and a world-changer, a hero for women’s rights. But his legacy isn’t one that uplifts women—it’s a legacy of bloodshed and brokenness. A legacy of death.
The [mifepristone] label reports that less than 0.5% of women “experienced serious adverse effects” (again, they aren’t including the baby’s death as an adverse effect). But this new robust, real-world study found it’s actually 10.93% of women! To put that into perspective, that’s 1 in 10 women who take mifepristone that suffer an adverse health effect!
And yet the BBC doesn’t report that ground-breaking research. Instead they trot out the tired, old argument that the abortion pill is as safe as over-the-counter pain relievers. That’s simply not true—it’s obviously not true for the baby who ends up dead nor for the mother who has a 1 in 10 chance of suffering a severe adverse health effect!
They trot out the tired, old argument that the abortion pill is as safe as over-the-counter pain relievers.
Baulieu’s widow said of him, “His research was guided by his commitment to progress through science, his dedication to women’s freedom and his desire to enable everyone to live better and longer lives,” and the French gender equality minister said Baulieu “was guided throughout his life by one requirement: that of human dignity.”
Really? Baulieu wanted “everyone” to live a better and longer life? He was guided by “human dignity”? He certainly didn’t apply that “commitment” to life or the “requirement” to be guided by human dignity to the millions of babies who were directly killed by the pill he invented and then fought to have legalized in countries around the world.
No, Baulieu was guided by a hatred of unborn life and the belief that women find freedom by killing their own children. What an evil worldview! A worldview that destroys the most vulnerable in the name of “freedom.”
Yes, the French president was right when he said that “few French people have changed the world to such an extent” as Baulieu did. He changed the world. . . . for the worse. He made the world a much more dangerous place—a deadly place—for unborn children and their mothers.
The Bible has a lot to say about such evil men:
Woe to the wicked! It shall be ill with him, for what his hands have dealt out shall be done to him. (Isaiah 3:11)
Ken Ham is the Founder CEO of Answers in Genesis and its two popular attractions: the acclaimed Creation Museum and the internationally known Ark Encounter, which features a life-size 510-foot-long Noah’s Ark—sometimes described as the “8th Wonder of the Modern World.” Each year, the two attractions host over 1.5 million guests.
A much-in-demand Christian speaker and interview guest, Ham became well known throughout America for his 2014 evolution/creation debate with Bill Nye, TV’s “The Science Guy.”
Ham hosts the daily radio program Answers, now on 1,000 stations. He’s also the founder of the award-winning Answers magazine. In 2020, Ham launched Answers TV, an ambitious streaming service. His website of AnswersInGenesis.org has twice won the top award from the National Religious Broadcasters for best website.
A prolific blogger and author of more than 30 books, Ham’s newest releases are Divine Dilemma (understanding death, disease, and suffering), Divided Nation (about today’s culture wars), and the devotional commentary Creation to Babel.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














